198 related articles for article (PubMed ID: 22363598)
21. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
22. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
[TBL] [Abstract][Full Text] [Related]
23. Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.
Mannella V; Boehm K; Celik S; Ali T; Mirza AN; El Hasnaouy M; Kaffa A; Lyu Y; Kafaei Golahmadi D; Leigh IM; Bergamaschi D; Harwood CA; Maffucci T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808215
[TBL] [Abstract][Full Text] [Related]
24. The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25.
Duarte A; Silveira GG; Soave DF; Costa JPO; Silva AR
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3377-3383. PubMed ID: 31759362
[TBL] [Abstract][Full Text] [Related]
25. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation.
Shin YK; Liu Q; Tikoo SK; Babiuk LA; Zhou Y
J Gen Virol; 2007 Mar; 88(Pt 3):942-950. PubMed ID: 17325368
[TBL] [Abstract][Full Text] [Related]
26. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
[TBL] [Abstract][Full Text] [Related]
27. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells.
Houben R; Adam C; Baeurle A; Hesbacher S; Grimm J; Angermeyer S; Henzel K; Hauser S; Elling R; Bröcker EB; Gaubatz S; Becker JC; Schrama D
Int J Cancer; 2012 Feb; 130(4):847-56. PubMed ID: 21413015
[TBL] [Abstract][Full Text] [Related]
28. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
[TBL] [Abstract][Full Text] [Related]
29. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma.
Amber K; McLeod MP; Nouri K
Dermatol Surg; 2013 Feb; 39(2):232-8. PubMed ID: 23387356
[TBL] [Abstract][Full Text] [Related]
30. [Merkel cell polyomavirus in the pathogenesis of non-melanoma skin cancer].
Zur Hausen A
Pathologe; 2009 Dec; 30 Suppl 2():217-20. PubMed ID: 19921198
[TBL] [Abstract][Full Text] [Related]
31. The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results.
Gambichler T; Majchrzak-Stiller B; Peters I; Becker JC; Strotmann J; Abu Rached N; Müller T; Uhl W; Buchholz M; Braumann C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10831-10840. PubMed ID: 37311987
[TBL] [Abstract][Full Text] [Related]
32. Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.
Sozopoulos E; Litsiou H; Voutsinas G; Mitsiades N; Anagnostakis N; Tseva T; Patsouris E; Tseleni-Balafouta S
Endocr Pathol; 2010 Jun; 21(2):90-100. PubMed ID: 20186503
[TBL] [Abstract][Full Text] [Related]
33. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.
Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR
Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406
[TBL] [Abstract][Full Text] [Related]
34. The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth.
Wu JH; Limmer AL; Narayanan D; Doan HQ; Simonette RA; Rady PL; Tyring SK
Clin Exp Dermatol; 2021 Dec; 46(8):1551-1554. PubMed ID: 34115902
[TBL] [Abstract][Full Text] [Related]
35. Chronic mTOR activation promotes cell survival in Merkel cell carcinoma.
Lin Z; McDermott A; Shao L; Kannan A; Morgan M; Stack BC; Moreno M; Davis DA; Cornelius LA; Gao L
Cancer Lett; 2014 Mar; 344(2):272-281. PubMed ID: 24262658
[TBL] [Abstract][Full Text] [Related]
36. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.
Krasagakis K; Metaxari M; Zervou M; Stathopoulos EN; Eberle J; Kanitakis J; Georgoulias V; Krüger-Krasagakis S; Tavernarakis N; Tosca AD
Anticancer Res; 2011 Mar; 31(3):807-11. PubMed ID: 21498700
[TBL] [Abstract][Full Text] [Related]
37. Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.
Ramakrishnan V; Kimlinger T; Haug J; Painuly U; Wellik L; Halling T; Rajkumar SV; Kumar S
PLoS One; 2012; 7(11):e50005. PubMed ID: 23185517
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors.
Pitt SC; Chen H; Kunnimalaiyaan M
Ann Surg Oncol; 2009 Oct; 16(10):2936-42. PubMed ID: 19588205
[TBL] [Abstract][Full Text] [Related]
39. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
Schrama D; Sarosi EM; Adam C; Ritter C; Kaemmerer U; Klopocki E; König EM; Utikal J; Becker JC; Houben R
Int J Cancer; 2019 Aug; 145(4):1020-1032. PubMed ID: 30873613
[TBL] [Abstract][Full Text] [Related]
40. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
